- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: lenalidomide
Total 1041 results
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Celgene CorporationTerminatedColorectal CancerAustralia, Belgium, Germany, Italy, Spain, Sweden
-
Robert Dreicer MDNational Cancer Institute (NCI)Completed
-
Seoul National University HospitalCompletedAmyloidosis CardiacKorea, Republic of
-
Seoul National University Bundang HospitalSamyang BioPharmRecruitingCentral Nervous System LymphomaKorea, Republic of
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
Seagen Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
Beijing Mabworks Biotech Co., Ltd.RecruitingFollicular Lymphoma and Marginal Zone LymphomaChina
-
Oslo University HospitalHelse Stavanger HF; St. Olavs Hospital; Nordic Myeloma Study GroupActive, not recruiting
-
Hackensack Meridian HealthCelgene CorporationCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
Weill Medical College of Cornell UniversityCelgeneCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene Corporation; Biologics...CompletedRelapsed/Refractory Mantle Cell LymphomaUnited States
-
Guangdong Provincial People's HospitalGuangzhou First People's Hospital; Foshan First People's Hospital; Huizhou Municipal... and other collaboratorsRecruitingDiffuse Large B Cell Lymphoma | Age Over 80 YearsChina
-
Institut Paoli-CalmettesCompletedAcute Myeloid Leukemia or Myelodysplasic SyndromeFrance
-
Fondazione EMN Italy OnlusActive, not recruiting
-
University of LeedsTakeda; Cancer Research UK; CelgeneRecruitingMultiple MyelomaUnited Kingdom
-
Kim, Seok JinCelltrion; Samyang Biopharmaceuticals CorporationRecruitingPrimary CNS LymphomaKorea, Republic of
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene CorporationCompletedRecurrent Follicular LymphomaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieCompletedLymphoma of the Mucosa Associated Lymphoid Tissue (MALT)Austria
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States, France, Australia
-
EnteromeRecruitingFollicular Lymphoma | Marginal Zone LymphomaUnited States, Italy, Spain
-
LiNingNot yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingNeoplasms by Histologic Type | Lymphoma, Large B-Cell, DiffuseChina
-
Ruijin HospitalNot yet recruitingLymphoma, Large B-Cell, DiffuseChina
-
Gruppo Italiano Malattie EMatologiche dell'AdultoTerminatedChronic Lymphocytic LeukemiaItaly
-
SCRI Development Innovations, LLCGenentech, Inc.; Celgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
Incyte CorporationActive, not recruitingFollicular Lymphoma | Marginal Zone LymphomaFinland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
-
Innovent Biologics (Suzhou) Co. Ltd.Withdrawn
-
Yan Zhang, MDPeking University First Hospital; Chinese PLA General Hospital; Peking University...Recruiting
-
Fudan UniversityUnknownDouble Expressor LymphomaChina
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
Duke UniversityCelgene CorporationCompletedMyelodysplastic SyndromesUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Fondazione Italiana Linfomi - ETSActive, not recruiting
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific
-
University of California, San DiegoCompletedCLL | Richter's SyndromeUnited States
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Duke UniversityCelgeneTerminatedFollicular Lymphoma | Marginal Zone LymphomaUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownMyelodysplastic SyndromeIsrael
-
Incyte Biosciences Japan GKRecruitingDiffuse Large B-cell Lymphoma | Non Hodgkins LymphomaJapan
-
Yale UniversityPeter MacCallum Cancer Centre, AustraliaTerminatedMultiple Myeloma | Hodgkin's Lymphoma | Mature T-cell LymphomaUnited States
-
Scripps HealthBristol-Myers Squibb; Celgene CorporationWithdrawnLeukemia | Chronic Lymphocytic Leukemia
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Hospital Universitario GetafeUnknown
-
Centre Hospitalier Universitaire, AmiensInstitut Bergonié; Centre Henri Becquerel; Saint-Louis Hospital, Paris, France; Henri Mondor University Hospital and other collaboratorsRecruitingChemotherapy | Elderly | Diffuse Large B-Cell Lymphoma (DLBCL), NosFrance
-
Wuerzburg University HospitalCelgene Corporation; ClinAssess GmbHActive, not recruitingPreviously Untreated Symptomatic Multiple MyelomaGermany
-
Groupe Francophone des MyelodysplasiesCelgeneCompletedLenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q (GFM-AZA-REV-09)Myelodysplastic SyndromesFrance
-
Nordic MDS GroupUnknownMyelodysplastic Syndrome | Acute Myelogenous LeukemiaSweden